Title |
Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis
|
---|---|
Published in |
Journal of Neuroinflammation, July 2014
|
DOI | 10.1186/1742-2094-11-124 |
Pubmed ID | |
Authors |
Conor Mc Guire, Lynn Elton, Peter Wieghofer, Jens Staal, Sofie Voet, Annelies Demeyer, Daniel Nagel, Daniel Krappmann, Marco Prinz, Rudi Beyaert, Geert van Loo |
Abstract |
The paracaspase mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) is crucial for lymphocyte activation through signaling to the transcription factor NF-κB. Besides functioning as a scaffold signaling protein, MALT1 also acts as a cysteine protease that specifically cleaves a number of substrates and contributes to specific T cell receptor-induced gene expression. Recently, small molecule inhibitors of MALT1 proteolytic activity were identified and shown to have promising anticancer properties in subtypes of B cell lymphoma. However, information on the therapeutic potential of small compound inhibitors that target MALT1 protease activity in autoimmunity is still lacking. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 2% |
Denmark | 1 | 2% |
Unknown | 59 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 19 | 31% |
Student > Master | 12 | 20% |
Student > Ph. D. Student | 7 | 11% |
Student > Doctoral Student | 5 | 8% |
Other | 3 | 5% |
Other | 6 | 10% |
Unknown | 9 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 15 | 25% |
Biochemistry, Genetics and Molecular Biology | 11 | 18% |
Medicine and Dentistry | 5 | 8% |
Immunology and Microbiology | 5 | 8% |
Chemistry | 4 | 7% |
Other | 10 | 16% |
Unknown | 11 | 18% |